tirzepatide for mash Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



















